{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T17:24:32Z","timestamp":1794331472931,"version":"4.9.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T00:00:00Z","timestamp":1685491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T00:00:00Z","timestamp":1685491200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2021R1A2C1006369"],"award-info":[{"award-number":["NRF-2021R1A2C1006369"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Parkinson\u2019s disease (PD) is an incurable movement disorder characterized by dopaminergic cell loss, neuroinflammation, and \u03b1-synuclein pathology. Herein, we investigated the therapeutic effects of necrosulfonamide (NSA), a specific inhibitor of mixed lineage kinase domain-like protein (MLKL), in a subacute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of PD. MLKL is an executor of necroptosis, a programmed cell death pathway that causes inflammation. Repeated administration of NSA resulted in the recovery of impaired motor performance and dopaminergic degeneration. Furthermore, NSA inhibited the phosphorylation, ubiquitylation, and oligomerization of MLKL, all of which are associated with MLKL cell death-inducing activity in dopaminergic cells in the substantia nigra (SN). NSA also inhibited microglial activation and reactive astrogliosis as well as the MPTP-induced expression of proinflammatory molecules such as tumor necrosis factor-\u03b1, interleukin-1\u03b2, inducible nitric oxide synthase, and cystatin F. Furthermore, NSA inhibited \u03b1-synuclein oligomerization and phosphorylation in the SN of MPTP-treated mice by inhibiting the activity of glycogen synthase kinase 3\u03b2 and matrix metalloproteinase-3. In conclusion, NSA has anti-necroptotic, anti-inflammatory, and anti-synucleinopathic effects on PD pathology. Therefore, NSA is a potential therapeutic candidate for PD.<\/jats:p>","DOI":"10.1038\/s41598-023-35975-y","type":"journal-article","created":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T10:02:24Z","timestamp":1685527344000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Necrosulfonamide exerts neuroprotective effect by inhibiting necroptosis, neuroinflammation, and \u03b1-synuclein oligomerization in a subacute MPTP mouse model of Parkinson\u2019s disease"],"prefix":"10.1038","volume":"13","author":[{"given":"Yea-Hyun","family":"Leem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Do-Yeon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung-Eun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee-Sun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,31]]},"reference":[{"issue":"6","key":"35975_CR1","doi-asserted-by":"publisher","first-page":"E961","DOI":"10.1073\/pnas.1613305114","volume":"114","author":"SA Conos","year":"2017","unstructured":"Conos, S. A. et al. Active MLKL triggers the NLRP3 inflammasome in a cell-intrinsic manner. Proc. Natl. Acad. Sci. U.S.A. 114(6), E961\u2013E969 (2017).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"35975_CR2","doi-asserted-by":"crossref","unstructured":"Kang, K., Park. C. & Chan, F. K. Necroptosis at a glance. J. Cell Sci. 137(17), jcs260091 (2022).","DOI":"10.1242\/jcs.260091"},{"issue":"6","key":"35975_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2017.286","volume":"8","author":"S Zhang","year":"2017","unstructured":"Zhang, S. et al. Necroptosis in neurodegenerative diseases: A potential therapeutic target. Cell Death. Dis. 8(6), e2905 (2017).","journal-title":"Cell Death. Dis."},{"key":"35975_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2022.916249","volume":"15","author":"X Zhang","year":"2022","unstructured":"Zhang, X. et al. Necrosulfonamide alleviates acute brain injury of intracerebral hemorrhage via inhibiting inflammation and necroptosis. Front. Mol. Neurosci. 15, 916249 (2022).","journal-title":"Front. Mol. Neurosci."},{"key":"35975_CR5","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/s41418-017-0012-4","volume":"25","author":"L Galluzzi","year":"2018","unstructured":"Galluzzi, L. et al. Molecular mechanisms of cell death: Recommendations of the Nomenclature Committee on Cell Death 2018. Cell Death. Differ. 25, 486\u2013541 (2018).","journal-title":"Cell Death. Differ."},{"key":"35975_CR6","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.immuni.2013.02.003","volume":"38","author":"A Kaczmarek","year":"2013","unstructured":"Kaczmarek, A., Vandenabeele, P. & Krysko, D. V. Necroptosis: the release of damage associated molecular patterns and its physiological relevance. Immunity 38, 209\u2013223 (2013).","journal-title":"Immunity"},{"key":"35975_CR7","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/nature08780","volume":"464","author":"Q Zhang","year":"2010","unstructured":"Zhang, Q. et al. Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature 464, 104\u2013107 (2010).","journal-title":"Nature"},{"issue":"2","key":"35975_CR8","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/nchembio711","volume":"1","author":"A Degterev","year":"2005","unstructured":"Degterev, A. et al. Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury. Nat. Chem. Biol. 1(2), 112\u2013119 (2005).","journal-title":"Nat. Chem. Biol."},{"issue":"1\u20132","key":"35975_CR9","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.cell.2011.11.031","volume":"148","author":"L Sun","year":"2012","unstructured":"Sun, L. et al. Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase. Cell 148(1\u20132), 213\u2013227 (2012).","journal-title":"Cell"},{"issue":"7","key":"35975_CR10","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1038\/cdd.2017.65","volume":"24","author":"S Grootjans","year":"2017","unstructured":"Grootjans, S., Berghe, T. V. & Vandenabeele, P. Initiation and execution mechanisms of necroptosis: an overview. Cell Death. Differ. 24(7), 1184\u20131195 (2017).","journal-title":"Cell Death. Differ."},{"issue":"1","key":"35975_CR11","doi-asserted-by":"publisher","first-page":"3150","DOI":"10.1038\/s41467-020-16819-z","volume":"11","author":"JM Hildebrand","year":"2020","unstructured":"Hildebrand, J. M. et al. A missense mutation in the MLKL brace region promotes lethal neonatal inflammation and hematopoietic dysfunction. Nat. Commun. 11(1), 3150 (2020).","journal-title":"Nat. Commun."},{"issue":"1","key":"35975_CR12","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.tibs.2018.11.002","volume":"44","author":"EJ Petrie","year":"2019","unstructured":"Petrie, E. J., Czabotar, P. E. & Murphy, J. M. The structural basis of necroptotic cell death signaling. Trends Biochem. Sci. 44(1), 53\u201363 (2019).","journal-title":"Trends Biochem. Sci."},{"issue":"1","key":"35975_CR13","doi-asserted-by":"publisher","first-page":"3364","DOI":"10.1038\/s41467-021-23474-5","volume":"12","author":"LR Garcia","year":"2021","unstructured":"Garcia, L. R. et al. Ubiquitylation of MLKL at lysine 219 positively regulates necroptosis-induced tissue injury and pathogen clearance. Nat. Commun. 12(1), 3364 (2021).","journal-title":"Nat. Commun."},{"key":"35975_CR14","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1038\/nn.4608","volume":"20","author":"A Caccamo","year":"2017","unstructured":"Caccamo, A. et al. Necroptosis activation in Alzheimer\u2019s disease. Nat. Neurosci. 20, 1236\u20131246 (2017).","journal-title":"Nat. Neurosci."},{"key":"35975_CR15","doi-asserted-by":"publisher","first-page":"E8788","DOI":"10.1073\/pnas.1714175114","volume":"114","author":"D Ofengeim","year":"2017","unstructured":"Ofengeim, D. et al. RIPK1 mediates a disease-associated microglial response in Alzheimer\u2019s disease. Proc. Natl. Acad. Sci. U.S.A. 114, E8788\u2013E8797 (2017).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"35975_CR16","doi-asserted-by":"publisher","first-page":"61","DOI":"10.15252\/emmm.201606566","volume":"9","author":"SH Yang","year":"2017","unstructured":"Yang, S. H. et al. Nec-1 alleviates cognitive impairment with reduction of Abeta and tau abnormalities in APP\/PS1 mice. EMBO Mol. Med. 9, 61\u201377 (2017).","journal-title":"EMBO Mol. Med."},{"key":"35975_CR17","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/jcbfm.2010.72","volume":"31","author":"FJ Northington","year":"2011","unstructured":"Northington, F. J. et al. Necrostatin decreases oxidative damage, inflammation, and injury after neonatal HI. J. Cereb. Blood. Flow. Metab. 31, 178\u2013189 (2011).","journal-title":"J. Cereb. Blood. Flow. Metab."},{"key":"35975_CR18","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s11064-014-1510-0","volume":"40","author":"X Su","year":"2015","unstructured":"Su, X. et al. Necrostatin-1 ameliorates intracerebral hemorrhage-induced brain injury in mice through inhibiting RIP1\/RIP3 pathway. Neurochem. Res. 40, 643\u2013650 (2015).","journal-title":"Neurochem. Res."},{"key":"35975_CR19","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.nbd.2014.04.002","volume":"68","author":"M Vieira","year":"2014","unstructured":"Vieira, M. et al. Ischemic insults induce necroptotic cell death in hippocampal neurons through the up-regulation of endogenous RIP3. Neurobiol. Dis. 68, 26\u201336 (2014).","journal-title":"Neurobiol. Dis."},{"key":"35975_CR20","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s13024-016-0081-8","volume":"11","author":"H Fan","year":"2016","unstructured":"Fan, H. et al. Reactive astrocytes undergo M1 microglia\/macrohpages-induced necroptosis in spinal cord injury. Mol. Neurodegener. 11, 14 (2016).","journal-title":"Mol. Neurodegener."},{"issue":"6","key":"35975_CR21","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1179\/2045772314Y.0000000224","volume":"38","author":"M Liu","year":"2015","unstructured":"Liu, M. et al. Necroptosis, a novel type of programmed cell death, contributes to early neural cells damage after spinal cord injury in adult mice. J. Spinal. Cord. Med. 38(6), 745\u2013753 (2015).","journal-title":"J. Spinal. Cord. Med."},{"key":"35975_CR22","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1016\/j.celrep.2018.01.089","volume":"22","author":"A Iannielli","year":"2018","unstructured":"Iannielli, A. et al. Pharmacological inhibition of necroptosis protects from dopaminergic neuronal cell death in Parkinson\u2019s disease models. Cell Rep. 22, 2066\u20132079 (2018).","journal-title":"Cell Rep."},{"key":"35975_CR23","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1038\/s41418-019-0408-4","volume":"27","author":"M O\u00f1ate","year":"2020","unstructured":"O\u00f1ate, M. et al. The necroptosis machinery mediates axonal degeneration in a model of Parkinson disease. Cell Death. Differ. 27, 1169\u20131185 (2020).","journal-title":"Cell Death. Differ."},{"key":"35975_CR24","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1186\/s12974-022-02584-x","volume":"19","author":"RJ Boyd","year":"2022","unstructured":"Boyd, R. J. et al. Neuroinflammation represents a common theme amongst genetic and environmental risk factors for Alzheimer and Parkinson diseases. J. Neuroinflam. 19, 223 (2022).","journal-title":"J. Neuroinflam."},{"key":"35975_CR25","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s40035-017-0099-z","volume":"6","author":"P Maiti","year":"2017","unstructured":"Maiti, P., Manna, J. & Dunbar, G. L. Current understanding of the molecular mechanisms in Parkinson\u2019s disease: Targets for potential treatments. Transl. Neurodegener. 6, 28 (2017).","journal-title":"Transl. Neurodegener."},{"key":"35975_CR26","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/s41582-020-0344-4","volume":"16","author":"EK Tan","year":"2020","unstructured":"Tan, E. K. et al. Parkinson\u2019s disease and the immune system\u2014associations, mcehanisms and therapeutics. Nat. Rev. Neurol. 16, 303\u2013318 (2020).","journal-title":"Nat. Rev. Neurol."},{"key":"35975_CR27","doi-asserted-by":"crossref","unstructured":"GBD 2016 Neurology Collaborators. Global, regional, and national burden of neurological disorders, 1990\u20132016: A systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 18, 459\u201348 (2019).","DOI":"10.1016\/S1474-4422(18)30499-X"},{"key":"35975_CR28","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.4103\/1673-5374.160108","volume":"10","author":"JR Wu","year":"2015","unstructured":"Wu, J. R. et al. Necrostatin-1 protection of dopaminergic neurons. Neural. Regen. Res. 10, 1120\u20131124 (2015).","journal-title":"Neural. Regen. Res."},{"key":"35975_CR29","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/s41374-019-0319-5","volume":"100","author":"QS Lin","year":"2020","unstructured":"Lin, Q. S. et al. RIP1\/RIP3\/MLKL mediates dopaminergic neuron necroptosis in a mouse model of Parkinson\u2019s disease. Lab. Invest. 100, 503\u2013511 (2020).","journal-title":"Lab. Invest."},{"key":"35975_CR30","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.3389\/fphar.2019.01538","volume":"10","author":"J Jiao","year":"2020","unstructured":"Jiao, J. et al. Necrosulfonamide ameliorates neurological impairment in spinal cord injury by improving antioxidative capacity. Front. Pharmacol. 10, 1538 (2020).","journal-title":"Front. Pharmacol."},{"issue":"20","key":"35975_CR31","doi-asserted-by":"publisher","first-page":"3386","DOI":"10.1021\/acschemneuro.0c00516","volume":"11","author":"TMK Motawi","year":"2020","unstructured":"Motawi, T. M. K., Abdel-Nasser, Z. M. & Shahin, N. N. Ameliorative effect of necrosulfonamide in a rat model of Alzheimer\u2019s disease: targeting mixed lineage kinase domain-like protein-mediated necroptosis. ACS Chem. Neurosci. 11(20), 3386\u20133397 (2020).","journal-title":"ACS Chem. Neurosci."},{"issue":"40","key":"35975_CR32","doi-asserted-by":"publisher","first-page":"68393","DOI":"10.18632\/oncotarget.19416","volume":"8","author":"Y Zhou","year":"2017","unstructured":"Zhou, Y. et al. The degradation of mixed lineage kinase domain-like protein promotes neuroprotection after ischemic brain injury. Oncotarget 8(40), 68393\u201368401 (2017).","journal-title":"Oncotarget"},{"key":"35975_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110576","volume":"130","author":"YH Leem","year":"2020","unstructured":"Leem, Y. H. et al. Papaverine inhibits \u03b1-synuclein aggregation by modulating neuroinflammation and matrix metalloproteinase-3 expression in the subacute MPTP\/P mouse model of Parkinson\u2019s disease. Biomed. Pharmacother. 130, 110576 (2020).","journal-title":"Biomed. Pharmacother."},{"key":"35975_CR34","doi-asserted-by":"crossref","unstructured":"Killinger, B. A. et al. The vermiform appendix impacts the risk of developing Parkinson's disease. Sci. Transl. Med. 10(465), eaar5280 (2018).","DOI":"10.1126\/scitranslmed.aar5280"},{"issue":"5","key":"35975_CR35","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1038\/cdd.2014.179","volume":"22","author":"JJ Credle","year":"2015","unstructured":"Credle, J. J. et al. GSK-3\u03b2 dysregulation contributes to Parkinson\u2019s-like pathophysiology with associated region-specific phosphorylation and accumulation of tau and \u03b1-synuclein. Cell Death. Differ. 22(5), 838\u2013851 (2015).","journal-title":"Cell Death. Differ."},{"key":"35975_CR36","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.expneurol.2010.06.017","volume":"225","author":"J Wills","year":"2015","unstructured":"Wills, J. et al. Elevated tauopathy and alpha-synuclein pathology in postmortem Parkinson\u2019s disease brains with and without dementia. Exp. Neurol. 225, 210\u2013218 (2015).","journal-title":"Exp. Neurol."},{"issue":"16","key":"35975_CR37","doi-asserted-by":"publisher","first-page":"14168","DOI":"10.1074\/jbc.M111.222430","volume":"286","author":"DH Choi","year":"2011","unstructured":"Choi, D. H. et al. Role of matrix metalloproteinase 3-mediated alpha-synuclein cleavage in dopaminergic cell death. J. Biol. Chem. 286(16), 14168\u201314177 (2011).","journal-title":"J. Biol. Chem."},{"issue":"15","key":"35975_CR38","doi-asserted-by":"publisher","first-page":"3942","DOI":"10.1523\/JNEUROSCI.4965-05.2006","volume":"26","author":"GK Tofaris","year":"2006","unstructured":"Tofaris, G. K. et al. Pathological changes in dopaminergic nerve cells of the substantia nigra and olfactory bulb in mice transgenic for truncated human alpha-synuclein (1\u2013120): implications for Lewy body disorders. J. Neurosci. 26(15), 3942\u20133950 (2006).","journal-title":"J. Neurosci."},{"key":"35975_CR39","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/sj.emboj.7601979","volume":"27","author":"G Hamilton","year":"2008","unstructured":"Hamilton, G. et al. Cystatin F is a cathepsin C-directed protease inhibitor regulated by proteolysis. EMBO J. 27, 499\u2013508 (2008).","journal-title":"EMBO J."},{"issue":"1","key":"35975_CR40","doi-asserted-by":"publisher","first-page":"6820","DOI":"10.1038\/s41598-018-25031-5","volume":"8","author":"W Duan","year":"2018","unstructured":"Duan, W. et al. Cystatin F involvement in adenosine A2A receptor-mediated neuroinflammation in BV2 microglial cells. Sci. Rep. 8(1), 6820 (2018).","journal-title":"Sci. Rep."},{"key":"35975_CR41","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1111\/jnc.12790","volume":"131","author":"A Villarreal","year":"2014","unstructured":"Villarreal, A. et al. S100B protein activates a RAGE-dependent autocrine loop in astrocytes: Implications for its role in the propagation of reactive gliosis. J. Neurochem. 131, 190\u2013205 (2014).","journal-title":"J. Neurochem."},{"key":"35975_CR42","doi-asserted-by":"publisher","first-page":"4430","DOI":"10.1038\/ncomms5430","volume":"5","author":"C Chen","year":"2014","unstructured":"Chen, C. et al. Role of astroglia in Down\u2019s syndrome revealed by patient-derived human-induced pluripotent stem cells. Nat. Commun. 5, 4430 (2014).","journal-title":"Nat. Commun."},{"key":"35975_CR43","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1093\/hmg\/ddm080","volume":"16","author":"C Iaccarino","year":"2007","unstructured":"Iaccarino, C. et al. Apoptotic mechanisms in mutant LRRK2-mediated cell death. Hum. Mol. Genet. 16, 1319\u20131326 (2007).","journal-title":"Hum. Mol. Genet."},{"key":"35975_CR44","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1006\/exnr.2000.7489","volume":"166","author":"NA Tatton","year":"2006","unstructured":"Tatton, N. A. Increased caspase 3 and Bax immunoreactivity accompany nuclear GAPDH translocation and neuronal apoptosis in Parkinson\u2019s disease. Exp. Neurol. 166, 29\u201343 (2006).","journal-title":"Exp. Neurol."},{"key":"35975_CR45","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/ncb2883","volume":"16","author":"Z Cai","year":"2014","unstructured":"Cai, Z. et al. Plasma membrane translocation of trimerized MLKL protein is required for TNF-induced necroptosis. Nat. Cell. Biol. 16, 55\u201365 (2014).","journal-title":"Nat. Cell. Biol."},{"issue":"1","key":"35975_CR46","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/cdd.2015.70","volume":"23","author":"DA Rodriguez","year":"2016","unstructured":"Rodriguez, D. A. et al. Characterization of RIPK3-mediated phosphorylation of the activation loop of MLKL during necroptosis. Cell Death. Differ. 23(1), 76\u201388 (2016).","journal-title":"Cell Death. Differ."},{"key":"35975_CR47","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.molcel.2014.03.003","volume":"54","author":"H Wang","year":"2014","unstructured":"Wang, H. et al. Mixed lineage kinase domain-like protein MLKL causes necrotic membrane disruption upon phosphorylation by RIP3. Mol. Cell. 54, 133\u2013146 (2014).","journal-title":"Mol. Cell."},{"key":"35975_CR48","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.tcb.2011.02.002","volume":"21","author":"IV Hinkson","year":"2011","unstructured":"Hinkson, I. V. & Elias, J. E. The dynamic state of protein turnover: It\u2019s about time. Trends Cell. Biol. 21, 293\u2013303 (2011).","journal-title":"Trends Cell. Biol."},{"issue":"36","key":"35975_CR49","doi-asserted-by":"publisher","first-page":"E7450","DOI":"10.1073\/pnas.1707531114","volume":"114","author":"S Liu","year":"2017","unstructured":"Liu, S. et al. MLKL forms disulfide bond-dependent amyloid-like polymers to induce necroptosis. Proc. Natl. Acad. Sci. U.S.A. 114(36), E7450\u2013E7459 (2017).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"35975_CR50","doi-asserted-by":"crossref","unstructured":"Frank D. et al. Activated MLKL attenuates autophagy following its translocation to intracellular membranes. J. Cell Sci. 132(5), jcs220996 (2019).","DOI":"10.1242\/jcs.220996"},{"key":"35975_CR51","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1038\/ncomms2534","volume":"4","author":"C Kim","year":"2013","unstructured":"Kim, C. et al. Neuron-released oligomeric \u03b1-synuclein is an endogenous agonist of TLR2 for paracrine activation of microglia. Nat. Commun. 4, 1562 (2013).","journal-title":"Nat. Commun."},{"key":"35975_CR52","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0079160","volume":"8","author":"C Roodveldt","year":"2013","unstructured":"Roodveldt, C. et al. Preconditioning of microglia by alpha-synuclein strongly affects the response induced by toll-like receptor (TLR) stimulation. PLoS ONE 8, e79160 (2013).","journal-title":"PLoS ONE"},{"key":"35975_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2021.105094","volume":"148","author":"T Zheng","year":"2021","unstructured":"Zheng, T. & Zhang, Z. Activated microglia facilitate the transmission of \u03b1-synuclein in Parkinson\u2019s disease. Neurochem. Int. 148, 105094 (2021).","journal-title":"Neurochem. Int."},{"key":"35975_CR54","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/387028","volume":"2015","author":"C Batassini","year":"2015","unstructured":"Batassini, C. et al. Striatal injury with 6-OHDA transiently increases cerebrospinal GFAP and S100B. Neural. Plast. 2015, 387028 (2015).","journal-title":"Neural. Plast."},{"key":"35975_CR55","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.nbd.2017.07.014","volume":"106","author":"R Rydbirk","year":"2017","unstructured":"Rydbirk, R. et al. Cytokine profiling in the prefrontal cortex of Parkinson\u2019s disease and multiple system atrophy patients. Neurobiol. Dis. 106, 269\u2013278 (2017).","journal-title":"Neurobiol. Dis."},{"key":"35975_CR56","doi-asserted-by":"publisher","first-page":"3336","DOI":"10.1093\/brain\/aws250","volume":"135","author":"K Sathe","year":"2012","unstructured":"Sathe, K. et al. S100B is increased in Parkinson\u2019s disease and ablation protects against MPTP induced toxicity through the RAGE and TNF-alpha pathway. Brain 135, 3336\u20133347 (2012).","journal-title":"Brain"},{"issue":"11","key":"35975_CR57","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1111\/cns.13715","volume":"27","author":"M Cai","year":"2021","unstructured":"Cai, M. et al. Sevoflurane preconditioning protects experimental ischemic stroke by enhancing anti-inflammatory microglia\/macrophages phenotype polarization through GSK-3\u03b2\/Nrf2 pathway. CNS Neurosci. Ther. 27(11), 1348\u20131365 (2021).","journal-title":"CNS Neurosci. Ther."},{"key":"35975_CR58","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.phrs.2015.03.010","volume":"97","author":"M Golpich","year":"2015","unstructured":"Golpich, M. et al. Glycogen synthase kinase-3 beta (GSK-3\u03b2) signaling: Implications for Parkinson\u2019s disease. Pharmacol. Res. 97, 16\u201326 (2015).","journal-title":"Pharmacol. Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-35975-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-35975-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-35975-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T17:07:20Z","timestamp":1685552840000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-35975-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,31]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["35975"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-35975-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,31]]},"assertion":[{"value":"6 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8783"}}